UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549

                                    FORM 10-Q

(MARK  ONE)
X         QUARTERLY  REPORT  PURSUANT  TO  SECTION  13  OR  15(D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934.
                  FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2003
                                       OR
               TRANSITION  REPORT  PURSUANT  TO  SECTION  13  OR  15(D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934
           FOR THE TRANSITION PERIOD FROM ____________ TO ____________

                        COMMISSION FILE NUMBER:  0-21802




                        N-VIRO INTERNATIONAL CORPORATION
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

                     DELAWARE                         34-1741211
        (STATE  OR  OTHER  JURISDICTION  OF        (IRS  EMPLOYER
          INCORPORATION  OR  ORGANIZATION)       IDENTIFICATION NO.)

       3450  W.  CENTRAL  AVENUE,  SUITE  328
       TOLEDO,  OHIO                                     43606
     (ADDRESS  OF  PRINCIPAL  EXECUTIVE  OFFICES)     (ZIP  CODE)

      REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:  (419) 535-6374

                              ---------------------

          Indicate  by  check  mark  whether  the  registrant  (1) has filed all
reports  required  to be filed by Section 13 or 15(d) of the Securities Exchange
Act  of 1934 during the preceding 12 months (or for such shorter period that the
registrant  was  required to file such reports), and (2) has been subject to the
filing  requirements  for  at  least  the  past  90  days.  Yes   X  No.
                                                                 ---

          Indicate  by check mark whether the registrant is an accelerated filer
(as  defined  in  Exchange  Act  Rule  12-2).  Yes  No    X
                                                        ----

          As  of  May  12,  2003,  2,577,433  shares  of  N-Viro  International
Corporation  $  .01  par  value  common  stock  were  outstanding.



PART  I  -  FINANCIAL  INFORMATION


ITEM  1.        FINANCIAL  STATEMENTS




                              N-VIRO INTERNATIONAL CORPORATION
                           CONSOLIDATED STATEMENTS OF OPERATIONS
                                        (Unaudited)


                                                                Three Months Ended March 31
                                                                      2003          2002
                                                                  ------------  -----------
                                                                          
Revenues. . . . . . . . . . . . . . . . . . . .                    $1,245,269   $1,417,779

Cost of revenues. . . . . . . . . . . . . . . .                       913,397      947,866
                                                                  ------------  -----------

Gross Profit. . . . . . . . . . . . . . . . . .                       331,872      469,913

Operating expenses:
Selling, general and administrative . . . . . .                       451,256      469,750
Patent litigation expense . . . . . . . . . . .                             -          545
                                                                  ------------  -----------
                                                                      451,256      470,295
                                                                  ------------  -----------

Operating loss. . . . . . . . . . . . . . . . .                      (119,384)        (382)

Nonoperating income (expense):
Interest and dividend income. . . . . . . . . .                         2,396        6,474
Interest expense. . . . . . . . . . . . . . . .                       (22,329)      (6,684)
Income from equity investment in joint venture.                         1,804       24,646
                                                                  ------------  -----------
                                                                      (18,129)      24,436
                                                                  ------------  -----------

Income (loss) before income taxes . . . . . . .                      (137,513)      24,054

Federal and state income taxes. . . . . . . . .                             -            -
                                                                  ------------  -----------

Net income (loss) . . . . . . . . . . . . . . .                     $(137,513)  $   24,054
                                                                    ==========  ===========


Basic and diluted earnings (loss) per share . .                     $   (0.05)  $     0.01
                                                                  ============  ===========

Weighted average common shares outstanding. . .                     2,577,433    2,577,433
                                                                  ============  ===========






                 See Notes to Consolidated Financial Statements






                                   N-VIRO INTERNATIONAL CORPORATION
                                      CONSOLIDATED BALANCE SHEETS

                                                                     'March 31, 2003    'December 31,
                                                                        (Unaudited)     2002 (Audited)
                                                                      -------------     --------------
ASSETS
------
                                                                                 
CURRENT ASSETS
Cash and cash equivalents:
Unrestricted . . . . . . . . . . . . . . . . . . . . . . . . . . .  $         13,698   $        4,935
Restricted . . . . . . . . . . . . . . . . . . . . . . . . . . . .                 -          400,000
Receivables:
Trade, net of allowance of $40,000 in 2003 and 2002. . . . . . . .           977,305          659,932
Notes and other. . . . . . . . . . . . . . . . . . . . . . . . . .            10,358           16,358
Prepaid expenses and other assets. . . . . . . . . . . . . . . . .           201,664          137,257
Inventory - stated at lower of cost or market. . . . . . . . . . .           117,440          117,440
                                                                    -----------------  ---------------
Total current assets . . . . . . . . . . . . . . . . . . . . . . .         1,320,465        1,335,922

Property and Equipment . . . . . . . . . . . . . . . . . . . . . .           527,877          559,095

Investment in Florida N-Viro, L.P. . . . . . . . . . . . . . . . .           492,387          490,583

Intangible and Other Assets. . . . . . . . . . . . . . . . . . . .         1,617,244        1,641,990
                                                                    -----------------  ---------------

                                                                    $      3,957,973   $    4,027,590
                                                                    =================  ===============

LIABILITIES AND STOCKHOLDERS' EQUITY
------------------------------------
CURRENT LIABILITIES
Current maturities of long-term debt . . . . . . . . . . . . . . .  $        335,771   $      392,078
Line-of-credit . . . . . . . . . . . . . . . . . . . . . . . . . .           341,172          656,087
Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . .         1,242,289          957,716
Accrued liabilities. . . . . . . . . . . . . . . . . . . . . . . .           437,275          370,251
                                                                    -----------------  ---------------
Total current liabilities. . . . . . . . . . . . . . . . . . . . .         2,356,507        2,376,132

Long-term debt, less current maturities. . . . . . . . . . . . . .           514,259          426,738

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY
Common stock, $.01 par value; authorized 7,000,000 shares; issued
2,700,933 shares . . . . . . . . . . . . . . . . . . . . . . . . .            27,010           27,010
Additional paid-in capital . . . . . . . . . . . . . . . . . . . .        13,495,602       13,495,602
Retained earnings (deficit). . . . . . . . . . . . . . . . . . . .       (11,750,515)     (11,613,002)
                                                                    -----------------  ---------------
                                                                           1,772,097        1,909,610
Less treasury stock, at cost, 123,500 shares . . . . . . . . . . .           684,890          684,890
                                                                    -----------------  ---------------
Total stockholders' equity . . . . . . . . . . . . . . . . . . . .         1,087,207        1,224,720
                                                                    -----------------  ---------------

                                                                    $      3,957,973   $    4,027,590
                                                                    =================  ===============



                 See Notes to Consolidated Financial Statements






                               N-VIRO INTERNATIONAL CORPORATION
                            CONSOLIDATED STATEMENTS OF CASH FLOWS
                                         (Unaudited)



                                                                 Three Months Ended March 31,
                                                                          2003         2002
                                                                      ----------    ---------
                                                                              

NET CASH USED BY OPERATING ACTIVITIES. . . . . . .                    $(102,845)    $(27,581)

CASH FLOWS FROM INVESTING ACTIVITIES
Collections on notes receivable. . . . . . . . . .                        6,000        3,279
Advances to related party - net. . . . . . . . . .                            -         (800)
Purchases of property and equipment. . . . . . . .                         (870)     (14,933)
Expenditures for intangible assets . . . . . . . .                       (9,820)     (23,938)
                                                                       -----------    ---------
Net cash used in investing activities. . . . . . .                       (4,690)     (36,392)

CASH FLOWS FROM FINANCING ACTIVITIES
Reductions to restricted cash and cash equivalents                      400,000            -
Net borrowings (payments) on line-of-credit. . . .                     (314,915)      80,000
Borrowings under long-term obligations . . . . . .                      336,003       71,811
Principal payments on long-term obligations. . . .                     (304,790)     (76,591)
                                                                     -----------    ---------
Net cash provided by financing activities. . . . .                      116,298       75,220
                                                                     ----------    ---------

NET INCREASE IN CASH AND CASH EQUIVALENTS. . . . .                        8,763       11,247

CASH AND CASH EQUIVALENTS BEGINNING. . . . . . . .                        4,935       45,427
                                                              ------------------   ---------

CASH AND CASH EQUIVALENTS ENDING . . . . . . . . .                     $ 13,698     $ 56,674
                                                                     ===========    =========


Supplemental disclosure of cash flows information:
     Cash paid during the three months ended for interest              $ 22,827     $  8,522
                                                                     ===========    =========

Non-cash investing and financing activities:
     During  the three months ending March 31, 2003, the Company paid $22,827 in
interest.

     During  the  three  months  ended  March 31, 2003, the Company issued stock
warrants  with  a  fair  value  of  $30,000  as  part  of  debt  refinancing.












                 See Notes to Consolidated Financial Statements


                N-VIRO INTERNATIONAL CORPORATION AND SUBSIDIARIES
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)

1.     ORGANIZATION  AND  BASIS  OF  PRESENTATION

     The  accompanying consolidated financial statements of N-Viro International
Corporation  (the "Company") are unaudited but, in management's opinion, reflect
all  adjustments  (including  normal  recurring  accruals)  necessary to present
fairly  such information for the period and at the dates indicated.  The results
of operations for the three months ended March 31, 2003 may not be indicative of
the  results  of  operations  for  the  year ended December 31, 2003.  Since the
accompanying  consolidated financial statements have been prepared in accordance
with  Article  10  of  Regulation  S-X,  they do not contain all information and
footnotes  normally  contained  in  annual  consolidated  financial  statements;
accordingly,  they should be read in conjunction with the consolidated financial
statements and notes thereto appearing in the Company's Form 10-K for the period
ending  December  31,  2002.

     The financial statements are consolidated as of March 31, 2003 and December
31,  2002  for  the  Company.  Adjustments  have  been  made  to  eliminate  all
intercompany  transactions.

     In  preparing financial statements in conformity with accounting principles
generally  accepted  in the United States of America, management makes estimates
and  assumptions  that affect the reported amounts of assets and liabilities and
disclosures  of  contingent  assets and liabilities at the date of the financial
statements,  as well as the reported amounts of revenues and expenses during the
reporting  period.  Actual  results  could  differ  from  those  estimates.  The
following  are certain significant estimates and assumptions made in preparation
of  the  financial  statements:

     The  accompanying financial statements have been prepared assuming that the
Company  will  continue  as  a  going  concern.  The Company has in the past and
continues  to  sustain  net  and operating losses.  In addition, the Company has
used  substantial amounts of working capital in its operations which has reduced
the  Company's  liquidity to a low level.  These matters raise substantial doubt
about  the  Company's  ability  to  continue  as a going concern.  The financial
statements  do  not  include  any adjustments relating to the recoverability and
classification  of  recorded  assets  or  the  amounts  and  classification  of
liabilities  that  may  result  from  the  outcome  of  these  uncertainties.

     Non-domestic  license  and  territory fees - The Company does not recognize
revenue on any non-domestic license or territory fee contracts until the cash is
received,  assuming  all  other  tests of revenue recognition are met. Canada is
excluded  from  this  definition  of  non-domestic.

     Allowance  for  Doubtful  Accounts  -  The  Company  estimates  losses  for
uncollectible  accounts  based  on  the aging of the accounts receivable and the
evaluation  of  the  likelihood  of  success  in  collecting  the  receivable.

     Property  and  Equipment/Long-Lived  Assets  -  Property  and  equipment is
reviewed  for impairment pursuant to the provisions of SFAS No. 144, "Accounting
for the Impairment or Disposal of Long-Lived Assets."  The carrying amount of an
asset  (group)  is  considered impaired if it exceeds the sum of our estimate of
the  undiscounted future cash flows expected to result from the use and eventual
disposition  of  the  asset  (group),  excluding  interest  charges.

     Equity  Method  Investment  -  The  Company accounts for its investments in
joint  ventures under the equity method.  The Company periodically evaluates the
recoverability  of  its  equity  investments in accordance with APB No. 18, "The
Equity  Method of Accounting for Investments in Common Stock."  If circumstances
were to arise where a loss would be considered other than temporary, the Company
would  record a write-down of excess investment cost.  Management has determined
that  no  write-down  was  required  at  March  31,  2003.

     Intangible  Assets  - Intangible assets deemed to have indefinite lives are
tested  for  impairment  by  comparing  the  fair value with its carrying value.
Significant  estimates used in the determination of fair value include estimates
of  future  cash  flows.  As  required  under  current accounting standards, the
Company  tests  for  impairment when events and circumstances indicate that the
assets  might  be  impaired  and  the  carrying value of those assets may not be
recoverable.

     Fair Value of Financial Instruments - The carrying amounts of cash and cash
equivalents,  receivables,  accounts payable and accrued liabilities approximate
their  fair  values  because  of  the  short-term  nature  of these instruments.
Management  believes  the  carrying  amounts  of  the current and long-term debt
approximate  their  fair  value  based on interest rates for the same or similar
debt  offered  to  the  Company having the same or similar terms and maturities.

     Income  Taxes  -  The Company assumes the deductibility of certain costs in
income  tax  filings  and  estimates the recovery of deferred income tax assets.


2.     RELATED  PARTY  TRANSACTIONS

     The Company has an unsecured receivable from a related party, N-Viro Energy
Systems,  Inc.,  a  corporation  of  which  Mr.  J.  Patrick  Nicholson  is  the
controlling  stockholder, of $24,606 at March 31, 2003.  The amount due from the
related party has been deemed to be noncurrent by management in the accompanying
balance  sheets.  No  additional  advances were made to the related party during
the  quarter  ended  March  31,  2003.


3.     LONG-TERM  DEBT

     During  the  three  months  ended  March 31, 2003, the Company closed on an
$845,000  credit facility with a local bank. This senior debt credit facility is
comprised  of  a $295,000 four year term note at 7.5% and a line of credit up to
$550,000  at  Prime plus 1 1/2% and secured by a first lien on all assets of the
Company.  The  Company  will  use  the  funds  to refinance existing debt and to
provide  working  capital. Previously, the Company had a $750,000 line of credit
with another financial institution, secured by a $400,000 restricted Certificate
of  Deposit,  required  and held by this financial institution. Effectively, the
former  line of credit provided only $350,000 of additional working capital. The
effective  increase in the line will provide the Company with additional working
capital,  and  the  debt refinance will provide lower cost and longer term debt,
improving  cash flow. To secure the credit facility, the Company was required by
the  financial  institution  to  obtain Additional Collateral of $100,000 from a
real  estate  mortgage  from  a  third  party. Messrs. J. Patrick Nicholson, the
Chairman  of  the Board and Consultant to the Company; Michael G. Nicholson, the
Company's Chief Operating Officer and a Director; Robert F. Nicholson, a Company
employee,  and  Timothy  J.  Nicholson,  a  Company employee, ("the Nicholsons")
collectively  provided the $100,000 Additional Collateral. In exchange for their
commitment,  the Company has agreed to provide the Nicholsons the following: (1)
an  annual  fee in an amount equal to two percent (2%) of the aggregate value of
the  Mortgage  or  Mortgages  encumbering  the  Additional Collateral, which fee
originally  shall  be  $2,000 per annum; (2) interest at an annual rate of 5% of
the  aggregate  value  of  the  Mortgage or Mortgages encumbering the Additional
Collateral  beginning on the first anniversary date of the closing of the Credit
Facility,  and (3) grant, jointly, a warrant to acquire in the aggregate, 50,000
shares  of  the  Company's  voting common stock at a purchase price of $0.90 per
share,  which  was the closing market price of the Company's common stock on the
prior  business  day  to  the  closing  of the Credit Facility. In addition, the
Company  granted  to  the  Nicholsons  a  lien  upon the Company's inventory and
accounts  receivable.  This  lien  is subordinated to both existing liens on the
Company's  assets and all liens granted by the Company in favor of the financial
institution  providing  the  Credit  Facility.  The  value  of  the  warrants is
estimated to be $30,000 based upon a calculation using the Black-Scholes pricing
model.  In  estimating the value of the warrants, the following assumptions were
used:  no  assumed  dividend  rate; risk-free interest rate of 2.05% on expected
life  of 3 years; and expected price volatility of 108%. The fair value is being
amortized  over  the  4-year  life  of  the  guarantee.


4.     CONTINGENCIES

     Prior  to  May  9,  2002, the Company's shares of voting, common stock were
traded  on the SmallCap Market of the National Association of Securities Dealers
Automated  Quotation  System  ("NASDAQ").  On Thursday, May 9, 2002, the Company
received  notice from the NASD that the Company's shares of voting, common stock
would  be  de-listed  effective  with  the open of business on May 10, 2002.  In
July,  2002  the  Company  decided  not  to  pursue further appeal of the NASD's
decision to de-list its voting common stock.  Currently, the Company's shares of
common  stock  are  traded  on the Over-The-Counter ("OTC") market.  The Company
does not believe that the delisting of its common stock from the Nasdaq SmallCap
Market  has or will have a material adverse effect on the financial condition or
results  of  operations  of  the Company.  The delisting of the Company's common
stock  from  NASDAQ,  however,  may  have  had  a material adverse effect on the
marketability  of  the  Company's  shares,  as  shares  traded on the OTC market
generally  experience  lower  trading  value  than those traded on the organized
exchanges.

     The  Company  leases  its  executive  and administrative offices in Toledo,
Ohio. The Company believes its relationship with its lessor is satisfactory. The
total  minimum  annual  rental  commitment through 2006 is approximately $56,000
each year. The total rental expense included in the statements of operations for
the  three  months  ended  March  31, 2003 and 2002 is approximately $14,000 and
$15,600,  respectively.  The  Company  also  leases  various  equipment  on  a
month-to-month  basis.

     During  1999, the Company entered into employment and consulting agreements
with two officers of the Company.  One employment agreement expired in July 2002
and  the  other will expire in June 2004.  Future compensation amounts are to be
determined  annually  by the Board.  In addition, one of the agreements provides
for  payment  of  life  insurance premiums and the provision of health insurance
coverage  to  the  officer and his spouse for their lives.  The present value of
estimated  costs  related  to  the  provisions  of  this  agreement  totaled
approximately $135,800 at March 31, 2003.  The cost was recognized over the term
of the employment agreement.  The Company charged $1,524 in payments against the
liability  for the three months ended March 31, 2003.  The consulting agreements
begin  upon  termination  of  the  respective  employment  agreements and extend
through  July  2015  and  June  2014,  respectively.  The agreements require the
officers  to  provide  minimum  future services to be eligible for compensation.


5.     NEW  ACCOUNTING  STANDARDS

     In June 2001, the Financial Accounting Standards Board ("FASB") issued SFAS
No.  142,  "Goodwill and Other Intangible Assets."  Under SFAS No. 142, goodwill
and  intangible  assets  deemed to have indefinite lives are no longer amortized
but  are subject to periodic impairment tests.  Other intangible assets continue
to  be  amortized  over  their  useful  lives.  SFAS  No. 142 was adopted by the
Company  in  2002.

     In  August  2001,  the  FASB  issued  SFAS  No.  143, "Accounting for Asset
Retirement  Obligations,"  which  is  effective the first quarter of fiscal year
2003.  SFAS  143  addresses  financial  accounting and reporting for obligations
associated  with the retirement of tangible long-lived assets and the associated
asset  retirement  cost.

     In  October  2001,  the  FASB  issued  SFAS  No.  144,  "Accounting for the
Impairment  or  Disposal of Long-lived Assets," which was adopted by the Company
in  2002.  SFAS  No.  144  supercedes  SFAS No. 121 and modifies and expands the
financial  accounting and reporting for the impairment or disposal of long-lived
assets  other  than  goodwill.

     In April 2002, the FASB issued SFAS No. 145, "Rescission of FASB Statements
No.  4,  44  and  64,  Amendment  of  FASB  Statement  No.  13,  and  Technical
Corrections."  Provisions  of  SFAS  No.  145 become effective in 2002 and 2003.
Under  SFAS  No. 145, gains and losses from the extinguishment of debt should be
classified  as  extraordinary items only if they meet the criteria of Accounting
Principles  Board  Opinion  No.  30.  SFAS  No.  145  also  addresses  financial
accounting  and  reporting for capital leases that are modified in such a way as
to  give  rise  to  a  new  agreement  classified  as  an  operating  lease.

     In  June  2002,  the  FASB  issued  SFAS  No.  146,  "Accounting  for Costs
Associated  with  Exit  or  Disposal Activities," which is effective for exit or
disposal  activities  initiated  after December 31, 2002. SFAS No. 146 nullifies
Emerging  Issues  Task  Force Issue No. 94-3, "Liability Recognition for Certain
Employee  Termination  Benefits  and  Other Costs to Exit an Activity (including
Certain  Costs Incurred in a Restructuring)." Under SFAS No. 146, a liability is
required  to  be recognized for costs, including certain lease termination costs
and  employee termination benefits, associated with an exit or disposal activity
when the liability is incurred. SFAS No. 146 applies to costs associated with an
exit  activity  that  does  not  involve  an entity newly acquired in a business
combination  or  with a retirement or disposal activity covered by SFAS Nos. 143
and  144.

     In  November  2002, the FASB issued FIN 45, which expands previously issued
accounting  guidance  and disclosure requirements for certain guarantees. FIN 45
requires  the  recognition  of  an  initial  liability  for the fair value of an
obligation assumed by issuing a guarantee. The provision for initial recognition
and  measurement  of  the  liability  will  be applied on a prospective basis to
guarantees  issued  or  modified  after  December  31,  2002.

     In  December  2002,  the  FASB  issued  SFAS  No.  148,  "Accounting  for
Stock-Based,  Compensation  -  Transition  and Disclosure," that amends SFAS No.
123,  "Accounting  for Stock-Based Compensation," to provide alternative methods
of  transition  to  the fair value method of accounting for stock-based employee
compensation. SFAS No. 148 also amends the disclosure provisions of SFAS No. 123
and  APB Opinion No. 28, "Interim Financial Reporting," to require disclosure in
the  summary  of  significant  accounting policies of the effects of an entity's
accounting  policy with respect to stock-based employee compensation on reported
net  income  and  earnings per share in annual and interim financial statements.
The  Statement  does  not amend SFAS No. 123 to require companies to account for
employee  stock  options using the fair value method. The Statement is effective
for  fiscal  years  beginning  after  December  15,  2002.

     The  adoption  of  the  new  standards  did  not,  or  is  not expected to,
materially  affect  the  Company's financial position and results of operations.


6.     SEGMENT  INFORMATION

     EARNINGS  VARIATION  DUE  TO  BUSINESS  CYCLES  AND  SEASONAL FACTORS.  The
Company's operating results can experience quarterly or annual variations due to
business cycles, seasonality and other factors.  The market price for its common
stock  may decrease if its operating results do not meet the expectations of the
market.

     For  the  first quarter of 2003, approximately 40% of the Company's revenue
is  from  management  operations,  57%  from  other domestic operations, 2% from
research  and  development  grants and the remaining 1% from foreign operations.
Sales  of  the  N-Viro  technology  are  affected by general fluctuations in the
business  cycles  in  the  United  States and worldwide, instability of economic
conditions  (such as the current conditions in the Asia Pacific region and Latin
America)  and  interest  rates, as well as other factors. In addition, operating
results  of  some  of the Company's business segments are influenced, along with
other  factors  such  as  interest  rates,  by  particular  business  cycles and
seasonality.

     COMPETITION.  The  Company does business in a highly competitive market and
has  fewer  resources  than  most of its competitors.  Businesses in this market
compete  within and outside the United States principally on the basis of price,
product  quality,  custom  design,  technical  support,  reputation,  equipment
financing  assistance  and reliability.  Competitive pressures and other factors
could  cause  the  Company  to lose market share or could result in decreases in
prices,  either  of  which could have a material adverse effect on its financial
position  and  results  of  operations.

     RISKS  OF DOING BUSINESS IN OTHER COUNTRIES.  The Company conducts business
in  markets  outside  the  United  States, and expects to continue to do so.  In
addition  to  the  risk  of  currency  fluctuations,  the  risks associated with
conducting  business  outside  the  United States include: social, political and
economic instability; slower payment of invoices; underdeveloped infrastructure;
underdeveloped  legal systems; and nationalization.  The Company has not entered
into any currency swap agreements which may reduce these risks.  The Company may
enter  into  such  agreements  in the future if it is deemed necessary to do so.
Current  economic  and  political conditions in the Asia Pacific and Middle East
regions  have  affected  the  Company  outlook for potential revenue there.  The
Company  cannot  predict  the  full  impact of this economic instability, but it
could  have  a  material  adverse  effect  on  revenues  and  profits.

     The  Company has determined that its reportable segments are those that are
based  on  the  Company's  method  of  internal  reporting, which segregates its
business  by  product  category  and  service  lines.  The  Company's reportable
segments  are  as  follows:

          Management  Operations  - The Company provides employee and management
services  to  operate  the  Toledo  Wastewater  Treatment  Facility.

          Other  Domestic  Operations  - Sales of territory or site licenses and
royalty  fees  to  use  N-Viro  technology  in  the  United  States.

          Foreign  Operations  -  Sale of territory or site licenses and royalty
fees  to  use  N-Viro  technology  in  foreign  operations.

          Research  and  Development  -  The  Company contracts with Federal and
State agencies to perform or assist in research and development on the Company's
technology.

     The  accounting  policies  of  the  segments  are the same as the Company's
significant  accounting  policies.  Fixed assets generating specific revenue are
identified  with  their respective segments and are accounted for as such in the
internal accounting records.  All other assets, including cash and other current
assets  and  all  long-term assets, other than fixed assets, are identified with
the Corporate segment.  The Company allocates a total of approximately 6% of its
labor  cost  contained  in  selling, general, and administrative expenses to the
segments,  to  reflect  the indirect cost of maintaining these segments.  All of
the net nonoperating income (expense) are non-apportionable and not allocated to
a  specific  segment.  The  Company accounts for and analyzes the operating data
for  its  segments  generally  by geographic location, with the exception of the
Management  Operations  and  Research  and Development segments.  These segments
represent  both a significant amount of business generated as well as a specific
location  and  unique  type  of  revenue.

     The  next two segments are divided between domestic and foreign sources, as
these  segments  differ  in  terms  of environmental and municipal legal issues,
nature of the waste disposal infrastructure, political climate, and availability
of  funds  for  investing  in  the Company's technology.  These factors have not
changed significantly over the past several years and are not expected to change
in  the  near  term.

     The  Research  and Development segment accounts for approximately 2% of the
total  year-to-date  revenue  of the Company, and is unlike any other revenue in
that  it  is  generated  as a result of a specific project to conduct initial or
additional  ongoing  research  into  the  Company's  emerging  technologies.


     The  table below presents information about the segment profits and segment
identifiable  assets  used by the chief operating decision makers of the Company
for  the  quarters  ended  March  31,  2003  and  2002  (dollars  in thousands):





                                      Other
                       Management    Domestic      Foreign     Research &
                       Operations   Operations   Operations    Development   Total
                       -----------  -----------  -----------  -------------  ------

                                                2003
                       ------------------------------------------------------------
                                                              
  Revenues. . . . . .  $       503  $       707  $        12  $         23   $1,245
  Cost of revenues. .          347          542            -            24      913
  Segment profits . .          156          165           12            (1)     332
  Identifiable assets          366          101            -             -      467
  Depreciation. . . .           14           11            -             -       25

                                                2002
                       ------------------------------------------------------------
  Revenues. . . . . .  $       519  $       784  $        13  $        102   $1,418
  Cost of revenues. .          383          463            1           101      948
  Segment profits . .          136          321           12             1      470
  Identifiable assets          303           83            -            49      435
  Depreciation. . . .            8           10            -             2       20



A  reconciliation  of  total  segment  revenues,  cost  of revenues, and segment
profits  to  consolidated revenues, cost of revenues, and segment information to
the  consolidated financial statements for the quarters ended March 31, 2003 and
2002  is  as  follows  (dollars  in  thousands):





                                                   2003     2002
                                                  -------  -------
                                                     
  Segment profits:
  Segment profits for reportable segments. . . .  $  332   $  470
  Corporate selling, general and administrative
  expenses and research and development costs. .    (451)    (470)
  Other income (expense) . . . . . . . . . . . .     (19)      24
                                                  -------  -------
  Consolidated earnings before taxes . . . . . .  $ (138)  $   24
                                                  =======  =======

  Identifiable assets:
  Identifiable assets for reportable segments. .  $  467   $  435
  Corporate property and equipment . . . . . . .      61      145
  Current assets not allocated to segments . . .   1,330    1,680
  Intangible and other assets not allocated to
  segments . . . . . . . . . . . . . . . . . . .   2,334    2,505
  Consolidated eliminations. . . . . . . . . . .    (234)    (234)
                                                  -------  -------
  Consolidated assets. . . . . . . . . . . . . .  $3,958   $4,531
                                                  =======  =======

  Depreciation and amortization:
  Depreciation for reportable segments . . . . .  $   25   $   20
  Corporate depreciation and amortization. . . .      42       40
                                                  -------  -------
  Consolidated depreciation and amortization . .  $   67   $   60
                                                  =======  =======



7.     INVESTMENT  IN  FLORIDA  N-VIRO,  L.  P.

     Florida N-Viro, L.P. was formed in January 1996 pursuant to a joint venture
agreement  between the Company and VFL Technology Corporation.  The Company owns
a  47.5%  interest  in  the  joint  venture.

     Condensed  financial  information of the partnership for the quarters ended
March  31,  2003  and  2002  is  as  follows:






                                              Quarter Ended March 31,
                                             ------------------------
                                                  2003         2002
                                                 -------    --------
                                                      
Net sales . . . . . . . . . . . .                  $905,532  $962,073
Gross profit. . . . . . . . . . .                    61,100   107,456
Income from continuing operations                     3,797    51,887
Net income. . . . . . . . . . . .                     3,797    51,887



8.     STOCK  OPTIONS

     The  Company  accounts for stock-based compensation issued to its employees
and  directors  in  accordance  with Accounting Principles Board Opinion No. 25,
"Accounting  for  Stock Issued to Employees."  Accordingly, no compensation cost
has been recognized for the stock option plans, as all options granted under the
plans  have an exercise price equal to the market value of the underlying common
stock  on  the  date  of  the  grant.  The  fair  value  of  options granted was
determined  using  the  Black-Scholes option pricing model.

     The  following  table  illustrates  the effect on net income (loss) and net
income  (loss)  per  share if the Company had applied the fair value recognition
provisions  of FASB Statement No. 123, "Accounting for Stock-based Compensation"
to  stock-based  employee  compensation:





                                                                       Three Months Ended March 31,
                                                                      -----------------------------
                                                                          2003           2002
                                                                      -----------    -----------
                                                                               
  Net income (loss), as reported . . . . . . . . . . . . . . . . . .  $ (137,513)     $  24,054

  Deduct: Total stock-based employee compensation
           expense determined under fair value based method for all
           awards, net of related tax effects. . . . . . . . . . . .     (18,621)       (65,287)
                                                                      -----------      ---------

  Pro forma net income (loss). . . . . . . . . . . . . . . . . . . .    (156,134)       (41,233)

  Earnings (loss) per share:
  Basic and diluted - as reported. . . . . . . . . . . . . . . . . .  $    (0.05)      $   0.01
                                                                      ===========      =========

  Basic and diluted - pro-forma. . . . . . . . . . . . . . . . . . .  $    (0.06)      $  (0.02)
                                                                      ===========      =========




ITEM  2.      MANAGEMENT'S  DISCUSSION  AND  ANALYSIS OF FINANCIAL CONDITION AND
RESULTS  OF  OPERATIONS

OVERVIEW

     The Company was incorporated in April, 1993, and became a public company on
October  12,  1993.  The  Company's  business  strategy  is to market the N-Viro
Process,  which  produces  an "exceptional quality" sludge product as defined in
the  Section  503  Sludge  Regulations  under  the Clean Water Act of 1987, with
multiple  commercial  uses.  To date, the Company's revenues primarily have been
derived from the licensing of the N-Viro Process to treat and recycle wastewater
sludge  generated  by municipal wastewater treatment plants and from the sale to
licensees of the alkaline admixture used in the N-Viro Process.  The Company has
also  operated  N-Viro  facilities  for  third  parties  on a start-up basis and
currently  operates  one  N-Viro  facility  on  a  contract  management  basis.

     Total  revenues  were  $1,245,000  for  the  quarter  ended  March 31, 2003
compared to $1,418,000 for the same period of 2002.  The net decrease in revenue
is  due  primarily  to a decrease in facility management fees, one-time licenses
and  research and development revenue.  The Company's cost of revenues decreased
to  $913,000  in  2003  from $948,000 for the same period in 2002, and the gross
profit  percentage  decreased  to  27% from 33% for the quarters ended March 31,
2003 and 2002.  This decrease in gross profit percentage is primarily due to the
decreased  share  of  one-time  license  revenue  in  the  first quarter of 2003
compared  to  2002,  and  increased  costs  associated with the sale of alkaline
admixture  and  the  Company's  soil  blending  operation  for  the same period.
Operating  expenses  decreased  for  the comparative period, while the Company's
share  of  the  income  of  a  joint  venture, the Company's interest in Florida
N-Viro, L.P., decreased for the same period of 2003.  These changes collectively
resulted in a net loss of approximately $138,000 for the quarter ended March 31,
2003  compared  to  net  income  of  $24,000  for  the  same  period  in  2002.

COMPARISON  OF  THREE  MONTHS ENDED MARCH 31, 2003 WITH THREE MONTHS ENDED MARCH
31,  2002

     Overall  revenue  decreased $173,000, or 12%, to $1,245,000 for the quarter
ended  March 31, 2003 from $1,418,000 for the quarter ended March 31, 2002.  The
net  decrease  in  revenue  was  due  primarily  to  the  following:

     a)  Sales of alkaline admixture decreased $6,000 from the same period ended
in  2002;

     b)  Revenue  from the service fees for the management of alkaline admixture
increased  $34,000  from  the  same  period  ended  in  2002;

     c)  The  Company's  processing  revenue,  including  facility  management
revenue,  showed  a  net decrease of $50,000 over the same period ended in 2002;

     d)  Miscellaneous  revenues increased $16,000 from the same period ended in
2002;

     e)  Licensing  of  the N-Viro Process, including territory fees, earned the
Company  $-0-  for  the  period,  a  decrease  of  $92,000  from  2002;  and,

     f)  Research and development revenue decreased $75,000 from the same period
ended  in  2002.

     Gross  profit  decreased $138,000, or 29%, to $332,000 for the three months
ended  March  31,  2003 from $470,000 for the three months ended March 31, 2002.
This  decrease  in  gross  profit  was primarily due to the decrease in one-time
license  fee  and facility management revenue, in addition to an increase in the
cost  of supplying alkaline admixture to all domestic facilities and cost of the
Company's  soil  blending  operation.  The  gross profit margin decreased to 27%
from 33%, and was primarily due to the decreased one-time license revenue in the
first  quarter  of 2003 compared to 2002 and increased costs associated with the
sale  of  alkaline  admixture  and the Company's soil blending operation for the
same  period.

     Operating  expenses  decreased  $19,000,  or  4%, to $451,000 for the three
months  ended  March 31, 2003 from $470,000 for the three months ended March 31,
2002.  The  decrease  was  primarily  due  to  a  decrease  of  $49,000  in
personnel-related  and selling costs, partially offset by an increase in outside
professional  fees  of  $30,000.

     As  a  result  of  the foregoing factors, the Company recorded an operating
loss  of  $119,000  for  the  three  months  ended March 31, 2003 compared to an
operating loss of $400 for the three months ended March 31, 2002, an increase in
the  loss  of  approximately  $119,000.

     Net nonoperating expense decreased by $43,000 to a net nonoperating expense
of  $18,000  for  the  three  months  ended March 31, 2003 from net nonoperating
income  of  $25,000 for the three months ended March 31, 2002.  The decrease was
primarily  due  to  an increase in interest expense of $16,000 and a decrease of
$23,000  in  the  equity  of  a joint venture, to $2,000 in 2003 from $25,000 in
2002.

     The  Company  recorded  a  net  loss of $138,000 for the three months ended
March  31,  2003  compared to net income of $24,000 for the same period ended in
2002,  a  decrease  in  net  profit  of  approximately  $162,000.

     For  the  three  months  ended March 31, 2003 and 2002, the Company has not
fully  recognized  the  tax  benefit  of  the  losses incurred in prior periods.
Accordingly,  the  effective  tax  rate  for  each  period  was  zero.


LIQUIDITY  AND  CAPITAL  RESOURCES

     The  Company had a working capital deficit of $1,026,000 at March 31, 2003,
compared  to  a  working  capital deficit of $1,040,000 at December 31, 2002, an
increase  in  working  capital  of  $14,000.  Current  assets  at March 31, 2003
included  cash  and investments of $15,000, which is a decrease of $391,000 from
December  31, 2002.  This decrease in cash and investments was the result of the
Company  closing on an $845,000 credit facility with a local bank, and redeeming
its $400,000 certificate of deposit in the transaction.  The increase in working
capital  was  principally  due to the credit facility obtained which assisted in
refinancing  existing  short-term debt to long-term, but offset by the operating
loss  for  the  three  month  period.

     In  the  first  quarter  of  2003  the  Company's  cash flow generated from
operations  was  a deficit of $103,000, a decrease of approximately $75,000 from
2002.  No  unusual  cash transactions were recorded in the first quarter of 2003
that  affected  cash  flow  from  operations.

     In  February  2003 the Company closed on an $845,000 credit facility with a
local  bank.  This  senior  debt credit facility is comprised of a $295,000 four
year  term note at 7.5% and a line of credit up to $550,000 at Prime plus 1 1/2%
and  secured by a first lien on all assets of the Company.  The Company will use
the  funds  to  refinance  existing  debt  and  to  provide  working  capital.
Previously,  the  Company  had  a $750,000 line of credit with another financial
institution,  secured  by a $400,000 restricted Certificate of Deposit, required
and  held by this financial institution.  Effectively, the former line of credit
provided only $350,000 of additional working capital.  The effective increase in
the  line will provide the Company with additional working capital, and the debt
refinance will provide lower cost and longer term debt, improving cash flow.  To
secure  the  credit  facility,  the  Company  was  required  by  the  financial
institution  to  obtain  Additional  Collateral  of  $100,000 from a real estate
mortgage  from a third party.  Messrs. J. Patrick Nicholson, the Chairman of the
Board  and  Consultant to the Company; Michael G. Nicholson, the Company's Chief
Operating  Officer  and a Director; Robert F. Nicholson, a Company employee, and
Timothy  J.  Nicholson,  a  Company  employee,  ("the  Nicholsons") collectively
provided  the $100,000 Additional Collateral.  In exchange for their commitment,
the  Company  has  agreed to provide the Nicholsons the following: (1) an annual
fee  in  an  amount  equal  to  two  percent  (2%) of the aggregate value of the
Mortgage  or  Mortgages  encumbering  the  Additional  Collateral,  which  fee
originally  shall  be $2,000.00 per annum;  (2) interest at an annual rate of 5%
of  the  aggregate value of the Mortgage or Mortgages encumbering the Additional
Collateral  beginning on the first anniversary date of the closing of the Credit
Facility,  and (3) grant, jointly, a warrant to acquire in the aggregate, 50,000
shares  of  the  Company's  voting common stock at a purchase price of $0.90 per
share,  which  was the closing market price of the Company's common stock on the
prior  business  day  to  the  closing of the Credit Facility.  In addition, the
Company  granted  to  the  Nicholsons  a  lien  upon the Company's inventory and
accounts  receivable.  This  lien  is subordinated to both existing liens on the
Company's  assets and all liens granted by the Company in favor of the financial
institution  providing  the  Credit  Facility.

     The  normal  collection  period  for  accounts receivable are approximately
45-60 days for the majority of customers.  This is a result of the nature of the
license  contracts,  type  of customer and the amount of time required to obtain
the  information to prepare the billing.  The Company did not change its reserve
for  bad  debts  during  the  first  quarter  of  2003.

     The  Company  is  currently  actively  pursuing  sale  of its investment in
Florida N-Viro, LP, which may provide, in management's opinion, additional funds
to  finance the Company's cash requirements.  Because these efforts are still in
progress, there can be no assurance the Company will successfully complete these
negotiations.

     The  Company paid certain amounts due to Hydropress Environmental Services,
Inc.  ("Hydropress")  under  a  Settlement Agreement dated December 14, 2001 and
pursuant  to  the  terms  of  a  promissory  note  (the "Hydropress Note").  The
original  principal amount of the Hydropress Note was $204,587, was non-interest
bearing  and matured on October 15, 2002 with a balloon payment of $144,587.  At
September 30, 2002, the outstanding principal balance on the Hydropress Note was
$144,587,  which was paid in full to Hydropress in October 2002.  In conjunction
with  the  final  discharge  of  the  Hydropress  Note,  the Company arranged an
unsecured  loan  from a third-party licensee for $144,587, with monthly payments
of  $13,966  due  for one year through October 15, 2003.  At March 31, 2003, the
outstanding  principal  balance  on  the  note  was  $89,190.

     The Company is currently working with the investment banking firm of Laux &
Company  of  Medina,  Ohio,  with  respect  to  a proposal to obtain up to $1.25
million  in equity financing.  The Company hopes to sell up to 500,000 shares of
preferred  stock  at  a  price  per  share  of  $2.50.  The  specific  terms and
conditions  applicable  to  the  preferred shares will be determined once Laux &
Company  has  identified  a potential purchaser.  There can be no assurance that
the  Company will be successful in finding a buyer for the preferred stock or in
selling  these  shares.  If  the shares are sold, the proceeds from the offering
will  be  used  to  supplement  the  Company's  working  capital.

     Also, the Company has gone forward on contracts with two investment banking
firms  with  respect  to  a  proposal to obtain up to $800,000 of mezzanine debt
financing.  The  specific  terms  and  conditions applicable to the debt will be
determined  once either firm has identified a potential debtor.  There can be no
assurance  that  the  Company  will  be  successful  in finding a lender for the
financing.  If the financing is obtained, the proceeds from the offering will be
used  to  supplement  the  Company's  working  capital.

     The  Company  is  currently  in  discussions  with several companies in the
cement  and  fuel  industries  for  the development and commercialization of the
patented  N-Viro  fuel  technology.  Because  these  discussions  are  still  in
progress,  there  can  be  no  assurance  they  will  be  successful.

     The  Company  continues  to  focus on the development of regional biosolids
processing  facilities.  Currently  the  Company is in negotiations with several
privatization  firms  to  permit  and  develop independent, regional facilities.

     The Company expects continued improvements in operating results for 2003 as
a  result  of  maintaining  lower  administrative costs, along with realized and
expected  new sources of revenue.  Additionally, market developments and ongoing
discussions  with  companies in the cement, fuel and wastewater industries could
provide  enhanced  liquidity  and  positively  impact  2003  operations.

     Current  market trends and Company business development provide significant
basis  for  the  Company's optimistic outlook for 2003 and beyond.  The national
public attack on Class B levels of sludge treatment is rapidly moving the market
to  Class  A  technologies, of which the Company's patented N-Viro processes are
very  cost  competitive,  and  well  established  in  the  market  place.  The
development  and  patenting  of  new  technologies  for animal manure treatment,
bio-fuel and nematode control have the potential to expand the Company's revenue
base  over  the  next  five  years  and  beyond.


RISK  FACTORS

THE  COMPANY'S  LICENSEES  ARE  SUBJECT  TO  EXTENSIVE  AND  INCREASINGLY STRICT
FEDERAL,  STATE  AND  LOCAL  ENVIRONMENTAL  REGULATION  AND  PERMITTING

     The  Company's  licensees  and their operations are subject to increasingly
strict  environmental  laws  and  regulations,  including  laws  and regulations
governing  the  emission,  discharge,  disposal  and  transportation  of certain
substances  and  related  odor.  Wastewater treatment plants and other plants at
which  our  biosolids  products  or  processes  may  be  implemented are usually
required to have permits, registrations and/or approvals from state and/or local
governments  for  the  operation  of  such  facilities.  Some  of our licensee's
facilities  require  air,  wastewater, storm water, biosolids processing, use or
siting  permits, registrations or approvals.  These licensees may not be able to
maintain  or  renew  their  current  permits  or  registrations or to obtain new
permits  or  registrations.  The  process  of  obtaining  a  required  permit or
registration  can  be  lengthy  and  expensive.  They  may  not  be able to meet
applicable  regulatory  or  permit requirements, and therefore may be subject to
related  legal  or  judicial  proceedings  that  could have a materially adverse
effect  on  our  income  derived  from  these  licensees.

     Any  of  the  permits,  registrations  or approvals noted above, or related
applications  may be subject to denial, revocation or modification, or challenge
by a third party, under various circumstances. In addition, if new environmental
legislation  or  regulations  are enacted or existing legislation or regulations
are  amended  or  are  enforced  differently, these licensees may be required to
obtain  additional,  or  modify  existing,  operating  permits, registrations or
approvals.

     Maintaining,  modifying  or  renewing  current  permits or registrations or
obtaining  new  permits  or registrations after new environmental legislation or
regulations  are  enacted  or existing legislation or regulations are amended or
enforced  differently  may be subject to public opposition or challenge. Much of
this  public opposition and challenge, as well as related complaints, relates to
odor  issues,  even  when our licensees are in compliance with odor requirements
and  even  though  the  licensee  has  worked  hard  to minimize odor from their
operations.  Public misperceptions about the business and any related odor could
influence  the governmental process for issuing such permits or registrations or
for  responding  to  any  such  public opposition or challenge. Community groups
could  pressure  local municipalities or state governments to implement laws and
regulations  which could increase our licensee's costs of its operations that in
turn  could  have  a  material  and adverse effect on the Company's business and
financial  condition.

THE  ABILITY  TO  GROW  MAY  BE  LIMITED  BY  COMPETITION

     The  Company  provides a variety of technology and services relating to the
treatment  of  wastewater  residuals.  The  Company  is  in  direct and indirect
competition  with other businesses that provide some or all of the same services
including regional residuals management companies and national and international
water  and  wastewater operations/privatization companies, technology suppliers,
municipal  solid  waste  companies  and  farming  operations.  Some  of  these
competitors  are  larger  and  have  greater  capital  resources.

     The Company derives a substantial portion of revenue from services provided
under municipal contracts, and many of these are subject to competitive bidding.
The  Company also intends to bid on additional municipal contracts, however, and
may not be the successful bidder. In addition, some of its contracts will expire
in  the  future  and those contracts may be renewed on less attractive terms. If
the  Company  is  not  able  to  replace  revenues  from  contracts lost through
competitive  bidding  or from the renegotiation of existing contracts with other
revenues within a reasonable time period, the lost revenue could have a material
and  adverse  effect  on  its  business,  financial  condition  and  results  of
operation.

THE  COMPANY'S  CUSTOMER  CONTRACTS MAY BE TERMINATED PRIOR TO THE EXPIRATION OF
THEIR  TERM.

     A  substantial  portion  of  the Company's revenue is derived from services
provided  under contracts and agreements with existing licensees.  Some of these
contracts,  especially  those  contracts  with large municipalities, provide for
termination  of  the contract by the customer after giving relative short notice
(in  some  cases  as  little as ten days).  In addition, some of these contracts
contain  liquidated  damages clauses, which may or may not be enforceable in the
event  of early termination of the contracts.  If one or more of these contracts
are  terminated  prior  to  the  expiration  of its term, and we are not able to
replace  revenues  from  the  terminated  contract or receive liquidated damages
pursuant  to  the  terms of the contract, the lost revenue could have a material
and  adverse  effect  on  our  business  and  financial  condition.

A  SIGNIFICANT  AMOUNT  OF THE COMPANY'S BUSINESS COMES FROM A LIMITED NUMBER OF
CUSTOMERS  AND  OUR  REVENUE AND PROFITS COULD DECREASE SIGNIFICANTLY IF WE LOST
ONE  OR  MORE  OF  THEM  AS  CUSTOMERS.

     The Company's business depends on provision of services to a limited number
of  customers.  One or more of these customers may stop contracting for services
from us or may substantially reduce the amount of services we provide them.  Any
cancellation, deferral or significant reduction in the services we provide these
principal customers or a significant number of smaller customers could seriously
harm  our  business  and  financial  condition.  For the quarter ended March 31,
2003,  our single largest customer accounted for approximately 40 percent of our
revenues  and  our top three customers accounted for approximately 69 percent of
our  revenues.

THE  COMPANY  IS  AFFECTED  BY  UNUSUALLY  ADVERSE  WEATHER  CONDITIONS

     The  Company's business is adversely affected by unusual weather conditions
and unseasonably heavy rainfall which can temporarily reduce the availability of
land  application  sites  in  close  proximity  to our operations.  In addition,
revenues  and  operational  results  are  adversely  affected  during  months of
inclement  weather  which  limits  the  level  of  land  application that can be
performed.  Long  periods  of  adverse  weather  could  have a material negative
effect  on  the  Company's  business  and  financial  condition.

FUEL  COST  VARIATION  COULD  AFFECT  OPERATING  RESULTS  AND  EXPENSES

     The  price  and  supply  of  fuel  is unpredictable and fluctuates based on
events  outside  our  control, including demand for oil and gas, actions by OPEC
and  other  oil  and  gas producers, and war in oil producing countries. Because
fuel  is  needed  for  the  trucks  that  purchase  the processing materials and
supplies  for  our  customers,  price escalations or reductions in the supply of
fuel could increase operating expenses and have a negative impact on the results
of operations. The Company is not always able to pass through all or part of the
increased  fuel  costs  due to the terms of certain customers' contracts and the
inability  to  negotiate  such  pass  through  costs  in  a  timely  manner.

THE  COMPANY  IS  DEPENDENT  ON  THE  MEMBERS  OF  ITS  MANAGEMENT  TEAM

     The Company is highly dependent on the services of its management team, the
loss  of  any  of  whom  may  have a material adverse effect on its business and
financial  condition.

     The  Company has entered into employment agreements with certain members of
its management team, which contain non-compete and other provisions. The laws of
each  state  differ concerning the enforceability of non-competition agreements.
The  Company cannot predict with certainty whether or not a court will enforce a
non-compete covenant in any given situation based on the facts and circumstances
at  that time. If one of its key executive officers were to leave and the courts
refused  to  enforce  the  non-compete covenant, the Company might be subject to
increased  competition,  which  could  have a material and adverse effect on its
business  and  financial  condition.

THE  COMPANY'S INTELLECTUAL PROPERTY MAY BE MISAPPROPRIATED OR SUBJECT TO CLAIMS
OF  INFRINGEMENT

     The  Company attempts to protect our intellectual property rights through a
combination  of  patent,  trademark, and trade secret laws, as well as licensing
agreements.  The  Company's failure to obtain or maintain adequate protection of
our  intellectual  property  rights for any reason could have a material adverse
effect  on  our  business  and  financial  condition.

     The  Company's  competitors,  many  of  whom  have  substantially  greater
resources  and  have made substantial investments in competing technologies, may
have applied for or obtained, or may in the future apply for and obtain, patents
that  will  prevent,  limit or otherwise interfere with the Company's ability to
offer  services.  The Company has not conducted an independent review of patents
issued  to  third  parties.

     The  Company  also  relies  on  unpatented  proprietary  technology.  It is
possible  that  others will independently develop the same or similar technology
or  otherwise  obtain  access  to  its  unpatented technology. If the Company is
unable  to  maintain  the  proprietary  nature  of our technologies, it could be
materially  adversely  affected.

     The  Company  cautions  that words used in this document such as "expects,"
"anticipates," "believes," "may," and "optimistic," as well as similar words and
expressions used herein, identify and refer to statements describing events that
may  or  may  not occur in the future.  These forward-looking statements and the
matters  to  which  they  refer are subject to considerable uncertainty that may
cause  actual  results  to  be materially different from those described herein.
Some,  but  not  all,  of  the  factors  that  could  cause actual results to be
different  than  those  anticipated  or predicted by the Company include:  (i) a
deterioration  in economic conditions in general;  (ii) a decrease in demand for
the Company's products or services in particular;  (iii) the Company's loss of a
key  employee  or  employees;  (iv)  regulatory  changes,  including  changes in
environmental regulations, that may have an adverse affect on the demand for the
Company's  products  or  services;  (v)  increases  in  the  Company's operating
expenses resulting from increased costs of labor and/or consulting services; and
(vi)  a  failure  to  collect  upon or otherwise secure the benefits of existing
contractual  commitments with third parties, including customers of the Company.
For  example,  while the Company anticipates obtaining the permits and approvals
necessary  for  the  Bio-Fuel pilot program to commence operations in 2003, such
program may not begin until 2004 or ever.  Delay or cancellation with respect to
this  project could result from  (1) a failure to achieve acceptable air quality
levels  in  preliminary  testing,  (2) costs associated with the use of Bio-Fuel
significantly  exceeding  current  estimates,  or  (3)  competing  technologies
rendering  the  Bio-Fuel  process  less  attractive.


ITEM  3.        QUANTITATIVE  AND  QUALITATIVE  DISCLOSURES  ABOUT  MARKET  RISK

     None.


ITEM  4.        CONTROLS  AND  PROCEDURES

     Within 90 days prior to the date of filing this Annual Report on Form 10-Q,
an  evaluation was performed under the supervision and with the participation of
our  management,  including  the  chief  executive  officer  and chief financial
officer,  of  the  effectiveness  of  the design and operation of our disclosure
controls  and procedures.  Based on that evaluation, our chief executive officer
and  chief  financial  officer  concluded  that  our  disclosure  controls  and
procedures  were effective as of March 31, 2003, and the evaluation date.  There
have  been  no  significant changes in our internal controls or in other factors
that  could significantly affect internal controls subsequent to the date of our
evaluation.



                           PART II - OTHER INFORMATION

ITEM  1.  LEGAL  PROCEEDINGS

          None

ITEM  2.  CHANGES  IN  SECURITIES  AND  USE  OF  PROCEEDS

     None


ITEM  3.  DEFAULTS  UPON  SENIOR  SECURITIES

     None


ITEM  4.  SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS

     None


ITEM  5.  OTHER  INFORMATION

     CHANGES  IN  REGISTRANT'S  BOARD  OF  DIRECTORS

          On  February  13, 2003, Wallace G. (Jack) Irmscher resigned as a Class
III member of the Board of Directors of the Company, effective at the end of the
Board  meeting  held  that  day.


ITEM  6.  EXHIBITS  AND  REPORTS  ON  FORM  8-K

     (a)  Exhibits:
               Exhibit  99.1  -  Certification(s) Pursuant to Section 906 of the
          Sarbanes-Oxley  Act  of  2002.

     (b)  Reports  on  Form  8-K:

               The  Company  filed a report on Form 8-K dated February 26, 2003,
          to  disclose  the  closing  on  an  $845,000  credit  facility.

               The  Company  filed  a report on Form 8-K dated March 4, 2003, to
          announce  the  date  of  the  2003  Annual  Stockholders  Meeting.



                        N-VIRO INTERNATIONAL CORPORATION




     Pursuant  to  the  requirements of the Securities Exchange Act of 1934, the
registrant  has  duly  caused  this  report  to  be  signed on its behalf by the
undersigned  thereunto  duly  authorized.



          N-VIRO  INTERNATIONAL  CORPORATION





Date:           May 20,  2003         /s/  Terry  J.  Logan
          ------------------          ---------------------
                                      Terry  J.  Logan
                                      Chief  Executive  Officer  and  President
                                     (Principal  Executive  Officer)




Date:           May 20,  2003         /s/  James  K.  McHugh
          ------------------          ----------------------
                                      James  K.  McHugh
                                      Chief  Financial  Officer,
                                      Secretary  and  Treasurer
                                      (Principal  Financial  &
                                      Accounting  Officer)


                        N-Viro International Corporation
                                 Certifications


I,  Terry  J.  Logan,  President  and  Chief  Executive  Officer,  certify that:

1.   I  have reviewed this quarterly report on Form 10-Q of N-Viro International
Corporation;

2.   Based  on  my  knowledge, this quarterly report does not contain any untrue
statement  of a material fact or omit to state a material fact necessary to make
the  statements  made, in light of the circumstances under which such statements
were  made,  not misleading with respect to the period covered by this quarterly
report;

3.   Based  on  my  knowledge,  the  financial  statements,  and other financial
information  included in the Report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of,  and  for,  the  periods  presented  in  this  quarterly  report;

4.   The  registrant's  other  certifying  officers  and  I  are responsible for
establishing  and  maintaining disclosure controls and procedures (as defined in
Exchange  Act  Rules  13a-14  and  15d-14)  for  the  registrant  and  we  have:

     a.  designed  such  disclosure  controls  and  procedures  to  ensure  that
material  information  relating  to  the  registrant, including its consolidated
subsidiaries,  is made known to us by others within those entities, particularly
during  the  period  in  which  this  quarterly  report  is  being  prepared;

     b.  evaluated the effectiveness of the registrant's disclosure controls and
procedures  as  of  a  date  within the 90 days prior to the filing date of this
quarterly  report  (the  "Evaluation  Date");

     c.  presented  in  this  quarterly  report  our  conclusions  about  the
effectiveness  of the disclosure controls and procedures based on our evaluation
as  of  the  Evaluation  Date;

5.   The  registrant's  other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit committee
of  registrant's  board  of  directors  (or  persons  performing  the equivalent
function);

     a.  all  significant  deficiencies  in  the design or operation of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and  have  identified for the
registrant's  auditors  any  material  weaknesses  in  internal  controls;  and

     b.  any  fraud,  whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

6.   The  registrant's  other  certifying  officers and I have indicated in this
quarterly  report  whether  or  not  there  were significant changes in internal
controls  or  in other factors that could significantly affect internal controls
subsequent  to  date  of their evaluation, including any corrective actions with
regard  to  significant  deficiencies  and  material  weaknesses.



Date:   May  20,  2003                /s/  Terry  J.  Logan
                                      ---------------------
                                      President  and  Chief  Executive  Officer

                        N-Viro International Corporation
                                 Certifications


I,  James  K.  McHugh,  Chief  Financial  Officer,  certify  that:

1.   I  have reviewed this quarterly report on Form 10-Q of N-Viro International
Corporation;

2.   Based  on  my  knowledge, this quarterly report does not contain any untrue
statement  of a material fact or omit to state a material fact necessary to make
the  statements  made, in light of the circumstances under which such statements
were  made,  not misleading with respect to the period covered by this quarterly
report;

3.   Based  on  my  knowledge,  the  financial  statements,  and other financial
information  included in the Report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of,  and  for,  the  periods  presented  in  this  quarterly  report;

4.   The  registrant's  other  certifying  officers  and  I  are responsible for
establishing  and  maintaining disclosure controls and procedures (as defined in
Exchange  Act  Rules  13a-14  and  15d-14)  for  the  registrant  and  we  have:

     a.  designed  such  disclosure  controls  and  procedures  to  ensure  that
material  information  relating  to  the  registrant, including its consolidated
subsidiaries,  is made known to us by others within those entities, particularly
during  the  period  in  which  this  quarterly  report  is  being  prepared;

     b.  evaluated the effectiveness of the registrant's disclosure controls and
procedures  as  of  a  date  within the 90 days prior to the filing date of this
quarterly  report  (the  "Evaluation  Date");

     c.  presented  in  this  quarterly  report  our  conclusions  about  the
effectiveness  of the disclosure controls and procedures based on our evaluation
as  of  the  Evaluation  Date;

5.   The  registrant's  other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit committee
of  registrant's  board  of  directors  (or  persons  performing  the equivalent
function);

     a.  all  significant  deficiencies  in  the design or operation of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and  have  identified for the
registrant's  auditors  any  material  weaknesses  in  internal  controls;  and

     b.  any  fraud,  whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

6.   The  registrant's  other  certifying  officers and I have indicated in this
quarterly  report  whether  or  not  there  were significant changes in internal
controls  or  in other factors that could significantly affect internal controls
subsequent  to  date  of their evaluation, including any corrective actions with
regard  to  significant  deficiencies  and  material  weaknesses.



Date:   May  20,  2003                    /s/  James  K.  McHugh
                                          ----------------------
                                          Chief  Financial  Officer